🇺🇸 FDA
Patent

US 7361664

Vitamin D receptor antagonists and related compositions and methods of use

granted A61PA61P17/00A61P17/06

Quick answer

US patent 7361664 (Vitamin D receptor antagonists and related compositions and methods of use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P17/00, A61P17/06, A61P19/08, A61P3/02